The Role of Immune Response in Viruses and Respiratory Allergy
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 147
Special Issue Editors
Interests: Eosinophilic asthma; allergic asthma; molecular diagnosis; respiratory allergies; biologic therapies; severe asthma; chronic Allergic rhinits; mast cell disorders; innate immunity in allergies; Th2 inflammation; vaccines; respiratory viruses
Interests: asthma; allergic asthma; molecular diagnosis; respiratory allergies; biologic therapies; severe asthma; chronic allergic rhinits; innate immunity in allergies
Special Issue Information
Dear Colleagues,
Respiratory allergic disorders are a frequent type of allergy with an increasing global incidence, especially for individuals living in urban areas. Viral infections can significantly exacerbate asthma, leading to severe disease courses and possibly fatal consequences. Notably, atopic subjects affected by respiratory allergies such as asthma have a low level of antiviral cytokines. Furthermore, innate immune cells activated by viral pathogens and viruses themselves contribute to the pathogenesis of eosinophilic inflammation. Research on the pathogenic mechanisms contributing to airway hyperresponsiveness, airway obstruction, and eosinophilic airway inflammation is ongoing. Indeed, the role of viral infections and the innate immune response in respiratory allergy is a growing field of research.
This Special Issue, “The Role of Immune Response in Viruses and Respiratory Allergy”, aims at collecting new evidence on immunologic, viral, and host factors contributing to the pathogenesis of respiratory exacerbations. Studies that shed light on the molecular mechanisms of the innate immune response during virosis in atopic subjects are welcome. We are pleased to invite you to submit articles focused on epidemiology, disease course, and the most common viral pathogens exacerbating respiratory conditions in allergic patients in clinical practice. Both original articles and reviews are welcome.
Dr. Mona Rita Yacoub
Dr. Maria Bernadette Cilona
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- asthma
- eosinophilic inflammation
- antiviral cytokines
- Th-2 response
- neutrophils
- eosinophils
- mast cells
- respiratory viruses
- rhinitis
